Capivasertib bulk supplier for pharma manufacturers

Capivasertib 160 mg Suppliers & Bulk Manufacturers

Q: What company makes Capivasertib?

Capivasertib (Truqap) is manufactured by AstraZeneca.

Q: What is generic name of Capivasertib?

The generic name is capivasertib.

Available Forms: Tablets

Available Strengths: 160 mg

Reference Brands: Truqap (USA)

Category: Oncology Cancer Care

Capivasertib is a Oncology Cancer Care product available as Tablets in strengths 160 mg. It corresponds to the reference brand Truqap (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Capivasertib, also known by the brand name Truqap, is an oral targeted anticancer therapy used in combination with fulvestrant for the treatment of adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It is specifically indicated for patients whose disease has progressed during or after prior hormone therapy and who have genetic alterations in the PIK3CA, AKT1, or PTEN genes.

Capivasertib works by selectively inhibiting AKT, a key protein involved in cell signaling pathways that regulate cancer cell growth, survival, and metabolism. By blocking AKT activity, capivasertib disrupts these pathways, helping to slow tumor growth and potentially induce cancer cell death. It belongs to the class of kinase inhibitors and represents an important advancement in precision oncology.

The drug is administered orally under specialist supervision and is being actively studied for use in other cancer types where AKT pathway abnormalities play a role. Capivasertib’s targeted mechanism allows for a more personalized treatment approach, offering improved outcomes for patients with specific molecular profiles while supporting long-term disease control in advanced breast cancer.

Capivasertib — third party manufacturing & bulk supply

Capivasertib 160 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Capivasertib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Capivasertib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Capivasertib →

Back to Listing

Frequently Asked Questions

Capivasertib is used in combination with endocrine therapy to treat adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer that has specific AKT pathway alterations.

Capivasertib is a small-molecule synthetic AKT inhibitor designed to block intracellular signaling pathways involved in cancer cell growth and survival.

The trade name is Truqap.

Capivasertib (Truqap) is manufactured by AstraZeneca.

The generic name is capivasertib.

The brand name is Truqap.

Capivasertib is manufactured in regulated pharmaceutical facilities under AstraZeneca’s global manufacturing network, supplying the USA, EU, and UK markets.